Cas:96-14-0 3-Methylpentane manufacturer & supplier

We serve Chemical Name:3-Methylpentane CAS:96-14-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Methylpentane

Chemical Name:3-Methylpentane
CAS.NO:96-14-0
Synonyms:EINECS 202-481-4;MFCD00009342;3-methylpentane
Molecular Formula:C6H14
Molecular Weight:86.17540
HS Code:2901100000

Physical and Chemical Properties:
Melting point:-118 °C
Boiling point:64 °C(lit.)
Density:0.664 g/mL at 25 °C(lit.)
Index of Refraction:n20/D 1.376(lit.)
PSA:
Exact Mass:86.10960
LogP:2.44250

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1208 3/PG 2
Packing Group:II


Contact us for information like EINECS 202-481-4 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-methylpentane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-methylpentane Use and application,MFCD00009342 technical grade,usp/ep/jp grade.


Related News: Under the plan, nonessential hospital staff members who belong to the union would not go to work on Monday. 3-Methylpentane manufacturer The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured. 3-Methylpentane supplier A number of UK citizens who failed to leave the coronavirus-struck Chinese city of Wuhan last week are now on a second flight to Europe, UK Foreign Secretary Dominic Raab said Sunday. 3-Methylpentane vendor A number of UK citizens who failed to leave the coronavirus-struck Chinese city of Wuhan last week are now on a second flight to Europe, UK Foreign Secretary Dominic Raab said Sunday. 3-Methylpentane factory Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly.